194 related articles for article (PubMed ID: 25685272)
21. The problems of radiofrequency ablation as an approach for advanced unresectable ductal pancreatic carcinoma.
Pezzilli R; Ricci C; Serra C; Casadei R; Monari F; D'Ambra M; Corinaldesi R; Minni F
Cancers (Basel); 2010 Jul; 2(3):1419-31. PubMed ID: 24281165
[TBL] [Abstract][Full Text] [Related]
22. Borderline resectable pancreatic cancer.
Hackert T; Ulrich A; Büchler MW
Cancer Lett; 2016 Jun; 375(2):231-237. PubMed ID: 26970276
[TBL] [Abstract][Full Text] [Related]
23. Radiofrequency ablation in pancreatic cancer.
Hlavsa J; Procházka V; Andrasina T; Pavlík T; Penka I; Kala Z
Rozhl Chir; 2019; 98(11):441-449. PubMed ID: 31948242
[TBL] [Abstract][Full Text] [Related]
24. Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer.
Paiella S; Salvia R; Girelli R; Frigerio I; Giardino A; D'Onofrio M; De Marchi G; Bassi C
Updates Surg; 2016 Sep; 68(3):307-311. PubMed ID: 27535401
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer.
Girelli R; Frigerio I; Salvia R; Barbi E; Tinazzi Martini P; Bassi C
Br J Surg; 2010 Feb; 97(2):220-5. PubMed ID: 20069610
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous Radiofrequency Ablation of Unresectable Locally Advanced Pancreatic Cancer: Preliminary Results.
D'Onofrio M; Crosara S; De Robertis R; Butturini G; Salvia R; Paiella S; Bassi C; Mucelli RP
Technol Cancer Res Treat; 2017 Jun; 16(3):285-294. PubMed ID: 27193941
[TBL] [Abstract][Full Text] [Related]
27. EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer: a randomized controlled trial (with videos).
Bang JY; Sutton B; Hawes RH; Varadarajulu S
Gastrointest Endosc; 2019 Jan; 89(1):58-66.e3. PubMed ID: 30120957
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic Radiofrequency Ablation of the Pancreas.
Rustagi T; Chhoda A
Dig Dis Sci; 2017 Apr; 62(4):843-850. PubMed ID: 28160105
[TBL] [Abstract][Full Text] [Related]
29. Surgical Treatment of Pancreatic Ductal Adenocarcinoma.
Wei K; Hackert T
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33923884
[TBL] [Abstract][Full Text] [Related]
30. Computed tomography findings after radiofrequency ablation in locally advanced pancreatic cancer.
Rombouts SJE; Derksen TC; Nio CY; van Hillegersberg R; van Santvoort HC; Walma MS; Molenaar IQ; van Leeuwen MS
Abdom Radiol (NY); 2018 Oct; 43(10):2702-2711. PubMed ID: 29492602
[TBL] [Abstract][Full Text] [Related]
31. Optimal combination of radiofrequency ablation with chemoradiotherapy for locally advanced pancreatic cancer.
Ikuta S; Kurimoto A; Iida H; Aihara T; Takechi M; Kamikonya N; Yamanaka N
World J Clin Oncol; 2012 Jan; 3(1):12-4. PubMed ID: 22247824
[TBL] [Abstract][Full Text] [Related]
32. Short term chemotherapy followed by radiofrequency ablation in stage III pancreatic cancer: results from a single center.
Frigerio I; Girelli R; Giardino A; Regi P; Salvia R; Bassi C
J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):574-7. PubMed ID: 23591744
[TBL] [Abstract][Full Text] [Related]
33. Oligometastatic Disease in Pancreatic Cancer - How to Proceed?
Renz BW; Boeck S; Roeder F; Trumm C; Heinemann V; Werner J
Visc Med; 2017 Mar; 33(1):36-41. PubMed ID: 28612015
[TBL] [Abstract][Full Text] [Related]
34. Contemporary management of borderline resectable pancreatic ductal adenocarcinoma.
Lekka K; Tzitzi E; Giakoustidis A; Papadopoulos V; Giakoustidis D
Ann Hepatobiliary Pancreat Surg; 2019 May; 23(2):97-108. PubMed ID: 31225409
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic ultrasound-guided ablation of branch-duct intraductal papillary mucinous neoplasms: Feasibility and safety tests using porcine gallbladders.
Park JS; Seo DW; Song TJ; Park do H; Lee SS; Lee SK; Kim MH
Dig Endosc; 2016 Jul; 28(5):599-606. PubMed ID: 26856542
[TBL] [Abstract][Full Text] [Related]
36. Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma.
Faraoni EY; Strickland LN; O'Brien BJ; Barraza JF; Thosani NC; Wray CJ; Mills TW; Bailey-Lundberg JM
Front Oncol; 2022; 12():995027. PubMed ID: 36147911
[TBL] [Abstract][Full Text] [Related]
37. Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.
Sommer CM; Pallwein-Prettner L; Vollherbst DF; Seidel R; Rieder C; Radeleff BA; Kauczor HU; Wacker F; Richter GM; Bücker A; Rodt T; Massmann A; Pereira PL
Eur J Radiol; 2017 Jan; 86():143-162. PubMed ID: 28027741
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency ablation in combination with an mTOR inhibitor restrains pancreatic cancer growth induced by intrinsic HSP70.
Gao S; Pu N; Yin H; Li J; Chen Q; Yang M; Lou W; Chen Y; Zhou G; Li C; Li G; Yan Z; Liu L; Yu J; Wang X
Ther Adv Med Oncol; 2020; 12():1758835920953728. PubMed ID: 32973929
[TBL] [Abstract][Full Text] [Related]
39. Surgical and local treatment of hepatic metastasis in pancreatic ductal adenocarcinoma: recent advances and future prospects.
Jin T; Dai C; Xu F
Ther Adv Med Oncol; 2020; 12():1758835920933034. PubMed ID: 32636941
[TBL] [Abstract][Full Text] [Related]
40. Impact of Endoluminal Radiofrequency Ablation on Immunity in Pancreatic Cancer and Cholangiocarcinoma.
Jarosova J; Macinga P; Krupickova L; Fialova M; Hujova A; Mares J; Urban O; Hajer J; Spicak J; Striz I; Hucl T
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
